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Abstract
Background
DYT1 dystonia is a heritable, early-onset generalized movement disorder caused by a GAG
deletion (ΔGAG) in the DYT1 gene. Neuroimaging studies and studies using mouse models
suggest that DYT1 dystonia is associated with dopamine imbalance. However, whether do-
pamine imbalance is key to DYT1 or other forms of dystonia continues to be debated.
Methodology/Principal Findings
We used Dyt1 knock out (Dyt1 KO), Dyt1 ΔGAG knock-in (Dyt1 KI), and transgenic mice
carrying one copy of the human DYT1 wild type allele (DYT1hWT) or human ΔGAGmutant
allele (DYT1hMT). D1R, D2R, and Gα(olf) protein expression was analyzed by western blot
in the frontal cortex, caudate-putamen and ventral midbrain in young adult (postnatal day
60; P60) male mice from all four lines; and in the frontal cortex and caudate putamen in juve-
nile (postnatal day 14; P14) male mice from the Dyt1 KI and KO lines. Dopamine receptor
and Gα(olf) protein expression were significantly decreased in multiple brain regions of
Dyt1 KI and Dyt1 KOmice and not significantly altered in the DYT1hMT or DYT1hWTmice
at P60. The only significant change at P14 was a decrease in D1R expression in the cau-
date-putamen of the Dyt1KOmice.
Conclusion/Significance
We found significant decreases in key proteins in the dopaminergic system in multiple brain
regions of Dyt1 KO and Dyt1 KI mouse lines at P60. Deletion of one copy of the Dyt1 gene
(KO mice) produced the most pronounced effects. These data offer evidence that impaired
dopamine receptor signaling may be an early and significant contributor to DYT1 dystonia
pathophysiology.
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Introduction
Dystonia is the third most common movement disorder after essential tremor and Parkinson’s
disease. It is a neurological disorder characterized by involuntary muscle contractions with de-
bilitating, painful, twisting movements and contorted postures [1]. Although the vast majority
of dystonia is sporadic, it can be inherited or may be a consequence of traumatic or vascular
brain injury or side effect of medications [2,3].
DYT1 dystonia is an inherited form of early onset generalized dystonia. It is inherited in an
autosomal dominant manner, and has relatively low penetrance [4,5]. A trinucleotide deletion
in the TOR1A gene, which results in the loss of a glutamic acid residue in the C-terminus re-
gion of the torsinA protein is linked to DYT1 dystonia [6]. TorsinA is a member of AAA
+ ATPase superfamily [6], associated with chaperone like functions in multiple processes in-
cluding protein folding and degradation, cytoskeletal dynamics, membrane trafficking, vesicle
fusion and transportation and secretion [7,8]. TorsinA mRNA is expressed in dopaminergic
neurons of the substantia nigra pars compacta, granule and pyramidal neurons of the hippo-
campus, Purkinje and granule neurons of the cerebellum, and cholinergic neurons of the neos-
triatum in humans [9,10].
Although the pathophysiological basis of dystonia remains elusive, it is believed to involve
dysfunction of motor circuits in the cerebral cortex, thalamus, cerebellum and basal ganglia
[11–13]. In particular, the striatal dopaminergic system is considered to be involved [13]. Re-
duced striatal D2R binding was reported in humans with various forms of dystonia including
DYT1 dystonia, idiopathic cervical dystonia, and nocturnal myoclonus [14–16]. In addition,
decreased dopamine release was reported in the DYT1 hMT transgenic mice [17].
Recently mutations in the gene for guanine nucleotide binding protein alpha subunit [Gα
(olf)], were found to be associated with primary dystonias, including some cases of early onset
generalized dystonia [18]. Gα(olf) is enriched in the striatum, and it forms heterotrimeric com-
plex with Gβ/Gγ7 [19]. These second messengers are coupled with dopamine D1 receptors,
suggesting further involvement of the dopaminergic system in another form of dystonia.
Despite the compelling evidence described above, involvement of the dopaminergic system
in dystonia remains a subject of debate. Moreover, whether changes in dopaminergic signaling
begin early in development is also not clear. Here, we examined D1R, D2R and Gα(olf) protein
expression in the frontal cortex, caudate putamen and ventral midbrain in four lines of DYT1
dystonia mouse models. We reasoned that a finding of dopaminergic dysfunction in multiple
models of DYT1 dystonia could add additional support for involvement of the dopaminergic
system in this form of dystonia.
Materials and Methods
Animals
The following mouse models were used: Heterozygous Dyt1 knock-out (Dyt1 KO), Dyt1 het-
erozygous ΔGAG knock-in (Dyt1 KI), hemizygous human DYT1 wild type transgenic (DYT1
hWT) and hemizygous human DYT1 ΔGAG transgenic (DYT1 hMT). The generation of the
mouse lines has been described previously [20–22]. Homozygous Dyt1 KO and Dyt1 KI mice
die within 2–3 days of birth, and only heterozygous mice are viable. DYT1 hWT and DYT1
hMTmice are hemizygous for the respective transgene (i.e. only one allele bore the transgene),
and survive to adulthood [21]. For each line we bred heterozygous or hemizygous mice with
wild type partners to produce wild type and hetero/hemizygous offspring. Offspring were gen-
otyped at the time of weaning using methods described previously [20–22]. We used wild type
littermates from each line as controls for that line. Mice were kept in temperature and humidity
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controlled rooms under a 12-h-light/dark cycle with free access to food and water in the labora-
tory animal facility at the Massachusetts General Hospital, Boston, MA. The experimental
studies were approved by the Massachusetts General Hospital’s Institutional Animal Care and
Use Committee (IACUC). All of the experimental procedures were in full compliance with in-
stitutional guidelines at the Massachusetts General Hospital and the NIH Guide for the Care
and Use of Laboratory Animals. The experiments were performed by investigators blinded to
the genotypes.
Western blot analysis
Postnatal day 14 (P14; day of birth = P0) and P60 male mice from each line along with wild
type male littermate controls were decapitated (mice were euthanized by anesthetic overdose
which is consistent with the recommendations of the Panel on Euthanasia of the American
Veterinary Medical Association) and the brains removed. Frontal cortex, caudate-putamen
and ventral midbrain were micro-dissected based on anatomical landmarks. Samples of each
region from the two hemispheres of a given brain were pooled such that there was only one
sample for each brain region from one mouse. Our expertise in microdissection and isolation
of different brain regions of the adult and developing mice [23–28], helps assure reliable sam-
pling of the brain regions. We were also concerned that volumetric changes in the brains of
transgenic mice could contribute variability to the sampling procedure. However, to the best of
our knowledge, volumetric changes in the caudate-putamen, frontal cortex or midbrain do not
exist in any of the mouse lines used here [20,21]. The tissue was homogenized in 200 μl of ice-
cold lysis buffer containing 50mM Tris-Cl (pH 7.4), 175mMNaCl, 5mM EDTA with a prote-
ase inhibitor cocktail tablet (Roche, 05892791001) and sonicated for 10 sec. Triton X-100 was
added to 1% w/v final concentration and the mixture was incubated on ice for 30 min and cen-
trifuged at 10,000 × g for 15 min at 4°C. The protein concentration was measured using the
Bradford assay with bovine serum albumin (BSA; Fisher Scientific, A7906) standard. The ho-
mogenates were mixed with SDS-PAGE loading buffer and boiled for 5 min, followed by
1-minute incubation on ice and 5 minutes of gentle centrifugation at 8,000g. The supernatant
was stored at -20°C till the day of analysis. 40 μg of each sample was loaded on a 10%
SDS-PAGE and the separated proteins were transferred to PVDF membrane. After blocking
with 5% BSA or 5% milk in TBS-T buffer, which contains 20mM Tris-Cl (pH 7.6), 137 mM
NaCl, 0.1% Tween 20, the membranes were incubated overnight at 4°C with rabbit anti-tor-
sinA antibody (1:500; Abcam, ab34540) in 5% milk TBS-T buffer, rabbit anti-D2R antibody
(1:500; Millipore, AB5084P) in 5% BSA TBS-T buffer (Abcam, Cambridge, MA), rabbit anti-
D1R antibody (1:200; Santa Cruz, sc-14001) in 3% BSA TBS-T buffer, rabbit anti-Gα(olf), anti-
body (1:500; Abcam, ab74049) in 5% BSA TBS-T buffer, or rabbit anti-Gα(S) antibody (1:500;
Santa Cruz, sc-823) in 3% BSA TBS-T buffer [29–35]. Membranes were washed three times
and incubated with bovine anti-rabbit IgG-HRP (1:15000; Santa Cruz, sc-2370) in 5% BSA
TBS-T at room temperature for 1 hour. β-actin was used as a loading control, and the mem-
branes were also probed with HRP-conjugated β-actin antibody (1:5000; Santa Cruz, sc-4778).
Immunoreactive bands were detected using Super Signal West Pico Chemiluminescent Sub-
strate (Thermo Scientific). The signals were captured by Alpha Innotech FluorChem FC2 and
quantified with UN-SCAN-IT gel (Silk Scientific) software. Each western blot experiment was
repeated three times.
Statistical analysis
Intensity of each band from each western blot for each experimental group (i.e. wild type and
transgenic) in each experiment was normalized to the intensity of the β-actin band (loading
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control) for that blot. Thus, expression of each protein [D1R, D2R or Gα(olf)] was analyzed in
independent and separate blots for every brain region in every mouse line and at each age.
Mean±SEM values of normalized band intensities were calculated for each protein by using
3–4 replications. Each brain sample was considered as one replication. Thus, we had 3 to 4 rep-
lications for each protein (n = 3 to 4). The data were analyzed using One-Way ANOVA, fol-
lowed by Bonferroni post hoc analysis (Prism 6 Software). A p-value smaller than 0.05 was
considered to be statistically significant.
Results
D1R expression
D1R expression in the frontal cortex, caudate putamen and ventral midbrain showed significant
changes in the Dyt1 KO [F = (5,12) = 63.88, P< 0.0001] and Dyt1 KI [F = (5,17) = 61.15,
P< 0.0001] lines of mice at P60 [Table 1]. Post hoc analysis revealed significant reductions in
D1R expression in the caudate-putamen and ventral midbrain regions in the Dyt1 KOmice
[Mean±SEM; caudate-putamen: WT = 1.36±0.10, KO = 1.08±0.03, p = 0.0084; ventral mid-
brain: WT = 0.72±0.03, KO = 0.45±0.05, p = 0.012; Fig 1A–1C] and only in the caudate-puta-
men in the Dyt1 KI mice [Mean±SEM; caudate-putamen: WT = 1.75±0.07, KI = 1.36±0.08,
p = 0.002; Fig 1E]. D1R expression was not significantly altered in the DYT1 hMT or hWTmice
[Fig 1G–1I, and S1 Table]. D1R expression at P14 [Table 2] showed significant changes only in
the Dyt1 KO line [F = (3,12) = 107.4, P< 0.0001, Fig 2B]. Post-hoc analysis revealed significant
reductions only in the caudate putamen of this mouse line [Mean±SEM; WT = 1.59±0.05,
KO = 1.40±0.05, p = 0.023, Fig 2B and S4 Table]. We did not analyze DYT1 hWT or hMT lines
of mice at P14.
Gα(olf) expression
Only the Dyt1 KOmice showed significant changes in Gα(olf) expression at P60
[F = (5,12) = 51.60, P< 0.0001, Table 1]. Post hoc analysis indicated a significant reduction
in the frontal cortex and ventral midbrain [Mean± SEM; frontal cortex: WT = 1.40±0.85,
KO = 0.84±0.05, p = 0.0003; ventral midbrain: WT = 1.87±0.08, KO = 0.90±0.07, p = 0.0001;
Fig 3A–3C]. Gα(olf) levels did not show significant changes in the Dyt1 KI, DYT1 hMT or
hWT mice [S2 Table]. We examined Gα(olf) expression in the Dyt1 KI and KO mice at P14
Table 1. A summary of the changes in D1R, D2R and Gα(olf) expression at P60.
P60 D1R P60 D2R P60 Gα(olf)
FC CP vMB FC CP vMB FC CP vMB
KO – # # # # # # – #
KI – # – # – – – – –
hWT – – – – – – N/A N/A N/A
hMT – – – – – – N/A N/A N/A
A summary of the changes in D1R, D2R and Gα(olf) expression at postnatal day 60 (P60) in the frontal cortex (FC), caudate-putamen (CP) and ventral
midbrain (vMB) in the Dyt1 KO (KO), Dyt1 KI (KI), human wild-type torsinA (hWT) and human mutant torsinA (hMT) lines of mouse.
# indicates statistically signiﬁcant reductions in expression compared to wild-type control mice.
—indicates no statistically signiﬁcant difference.
N/A differences were not analyzed.
doi:10.1371/journal.pone.0123104.t001
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Fig 1. D1R expression at P60. D1R expression in the frontal cortex, caudate-putamen and ventral midbrain of postnatal day 60 (P60; A-I) mice. In each
panel, the upper band shows D1R and the lower band shows β-actin, which was used as a loading control. The bar graphs in each panel represent D1R band
intensity (mean ± SEM) normalized to intensity of the loading control (integrated density value; IDV). The names of the mouse lines (Dyt1 KO, Dyt1 KI, hMT)
are indicated to the right. (*p<0.05, **p<0.01; n = 3 or 4).
doi:10.1371/journal.pone.0123104.g001
Dopamine Receptors and DYT1 Dystonia
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[Table 2]. However, neither line of mouse showed significant changes in any of the brain re-
gions examined [S5 Table].
Specificity of the Gα(olf) antibody was verified by the manufacturer using a peptide con-
taining amino acids 60–90 of human Gα(olf) protein. The peptide used as the immunogen for
this antibody has no homology with Gα(s). Since Gα(olf) and Gα(s) share homology, and since
Gα(s) is not associated with dystonia, it became necessary to verify that the changes in Gα(olf)
reported above were not somehow influenced by potential changes in Gα(s). Toward that end
we performed additional studies using a Gα(s) polyclonal antibody (Santa Cruz, sc-823), which
recognizes a 15–20 amino acid epitope that maps to a 50 amino acid stretch (aa 100–150) of
the Gα(s) protein (accession number P63092). The short and long forms of Gα(s) only differ
between each other at residues 71–72 and 73–86. Since this difference lies outside the amino
acid sequence used to raise the antibody, the antibody detects both forms of the protein. We ex-
amined Gα(s) protein expression in every brain region of the Dyt1 KOmice in which signifi-
cant reductions in Gα(olf) protein were found. Our data show that expression levels of neither
the short nor the long form of Gα(s) protein were significantly different between the WT and
the Dyt1 KO in any brain region examined [F = (5,12) = 3.099, P> 0.05, Mean± SEM; frontal
cortex: WT = 1.27±0.17, KO = 1.26±0.20; ventral midbrain: WT = 1.29±0.03, KO = 1.29±0.03
Fig 4A and 4B].
We performed two additional studies to confirm specificity of the Gα(olf) antibody. First,
we compared expression levels of Gα(olf) in the caudate putamen and frontal cortex of wild
type P60 mice. Consistent with earlier reports using different Gα(olf) antibodies [36,37], Gα
(olf) expression detected by the antibody used here was higher in the caudate putamen com-
pared to the frontal cortex [Fig 4C]. Next, we examined Gα(olf) expression in samples of the
caudate putamen obtained from adult heterozygous Gnal knockout mice [38]. We found a
56% reduction in Gα(olf) expression in the heterozygous samples [Fig 4D]. Based on these ob-
servations we suggest that the Gα(olf) antibody used here is capable of detecting the mouse Gα
(olf) protein.
Although the Gα(olf) antibody identified a single prominent 50 KDa band, consistent with
the molecular weight of the Gα(olf) protein, in the frontal cortex sample (Fig 4C), additional
bands were recognized in the caudate putamen samples (Fig 4C and 4D). Virtually all the
bands, not only the 50 KDa band, showed reduced intensity in the caudate putamen of the
Gnal knockout mouse (Fig 4D). We suggest that the additional bands identified by this anti-
body represent some form of posttranslational modification of the Gα(olf) protein, especially
in the caudate putamen, and that the reduction in the Gα(olf) protein in the Gnal knockout
mouse not only leads to a decrease in the 50 KDa species but also in the other forms of the Gα
(olf) protein.
Table 2. A summary of the changes in D1R, D2R and Gα(olf) expression at P14.
D1R D2R Gα(olf)
FC CP FC CP FC CP
KO – # – – – –
KI – – – – – –
A summary of the changes in D1R, D2R and Gα(olf) expression at postnatal day 14 (P14) in the frontal
cortex (FC) and caudate-putamen (CP) in the Dyt1 KO (KO) and Dyt1 KI (KI) lines of mouse.
# indicates statistically signiﬁcant reductions in expression compared to wild-type control mice.
—indicates no statistically signiﬁcant difference.
doi:10.1371/journal.pone.0123104.t002
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D2R expression
D2R expression was significantly altered at P60 [Table 1] in the Dyt1 KO [F = (5,12) = 26.88,
P< 0.0001], and Dyt1 KI lines (F = (5,18) = 44.60, P< 0.0001). Post hoc analysis indicated
significant reductions in the frontal cortex, caudate-putamen and ventral midbrain of the
Dyt1 KO line [Mean± SEM; frontal cortex: WT = 1.08±0.09, KO = 0.63±0.05, p< 0.0005; cau-
date-putamen: WT = 0.78± 0.07, KO = 0.51± 0.05, p< 0.021; ventral midbrain: WT = 0.57
Fig 2. D1R expression at P14.D1R expression in the frontal cortex and caudate-putamen of postnatal day
14 (P14; A- D) mice. In each panel, the upper band shows D1R and the lower band shows β-actin, which was
used as a loading control. The bar graphs in each panel represent D1R band intensity (mean ± SEM)
normalized to intensity of the loading control (integrated density value; IDV). The names of the mouse lines
(Dyt1 KO, Dyt1 KI) are indicated to the right. (*p<0.05, n = 3 or 4).
doi:10.1371/journal.pone.0123104.g002
Dopamine Receptors and DYT1 Dystonia
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±0.05, KO = 0.15±0.01, p< 0.001; Fig 5A–5C], as well as the frontal cortex,of the Dyt1 KI line
[Mean± SEM; frontal cortex: WT = 2.04± 0.11, KI = 1.68±0.09, p< 0.031 Fig 5D]. Whereas
the P60 DYT1 hMT and hWT mice did not display any significant changes in D2R expression
in any brain region [S3 Table] Similarly, we did not find significant changes in D2R expres-
sion in any brain region of the Dyt1 KI or KO mice at P14 [Table 2 and S6 Table].
Fig 3. Gα(olf) and Gα(s) expression at P60.Gα(olf) and Gα(s) expression in the frontal cortex, caudate-putamen and ventral midbrain of Dyt1 KO, and,
Dyt1 KI mice at postnatal day 60 (P60; A-F). In each panel, the upper band shows Gα(olf) (A-F), and the lower band shows β-actin, which was used as a
loading control. The bar graphs in each panel represent Gα(olf) band intensity (mean ± SEM) normalized to intensity of loading control (integrated density
value; IDV). The names of the mouse lines (Dyt1 KO, Dyt1 KI) are indicated to the right (**p<0.01, ***p<0.001; n = 3 or 4).
doi:10.1371/journal.pone.0123104.g003
Dopamine Receptors and DYT1 Dystonia
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Fig 4. Gα(s) and Gα(olf) expression at P60.Gα(s) and Gα(olf) expression in the frontal cortex, caudate-putamen and ventral midbrain of Dyt1 KO and Gnal
KOmice at postnatal day 60 (P60; A-D). In each panel, the upper band shows Gα(s) (Fig 4A and 4B), and Gα(olf) (Fig 4C and 4D), and the lower band shows
β-actin, which was used as a loading control. The bar graphs in each panel represent Gα(s), and Gα(olf) band intensity (mean ± SEM) normalized to intensity
of loading control (integrated density value; IDV). The names of the mouse lines (Dyt1 KO, andGnal KO) are indicated to the right.
doi:10.1371/journal.pone.0123104.g004
Dopamine Receptors and DYT1 Dystonia
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Fig 5. D2R expression at P60. D2R expression in the frontal cortex, caudate-putamen and ventral midbrain of postnatal day 60 (P60; A-I) mice. In each
panel, the upper band shows D2R and the lower band shows β-actin, which was used as a loading control. The bar graphs in each panel represent D2R band
intensity (mean ± SEM) normalized to intensity of loading control (integrated density value; IDV). The names of the mouse lines (Dyt1 KO, Dyt1 KI, hMT) are
indicated to the right (*p<0.05, **p<0.01; n = 3 or 4).
doi:10.1371/journal.pone.0123104.g005
Dopamine Receptors and DYT1 Dystonia
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Relationship among genotype, developmental stage, brain region and
dopamine receptor expression
The use of Dyt1 KI and Dyt1 KO lines of mice and the availability of juvenile (P14) and young
adult (P60) developmental time periods offered us the opportunity to evaluate the relative im-
pact of the loss of torsinA (Dyt1 KO) versus the presence of the mutant torsinA (Dyt1 KI), and
the impact of developmental stage (P14 versus P60) on the expression of D1R and D2R pro-
teins in the frontal cortex and the caudate-putamen. The reductions in D2R protein expression
in the frontal cortex and caudate-putamen were greater in magnitude in the Dyt1 KOmice
compared to the Dyt1 KI mice at P60 [Table 3]. At P14, only the Dyt1 KO caudate-
putamen showed significant changes (reductions) in the D1R protein [Table 3]. Thus, geno-
type, developmental stage and brain region appeared to impact D1R and D2R expression.
Since the hWT and hMT lines were not analyzed at P14, similar comparisons were not per-
formed for those lines.
Discussion
Our data show that dopamine receptor and Gα(olf) protein expression are significantly de-
creased in multiple brain regions of Dyt1 KI and Dyt1 KOmice whereas the expression is not
altered in the hMT or hWTmice at P60 [Table 1]. In the juvenile mice (P14) significant de-
creases occurred in D1R in the caudate-putamen of the Dyt1 KOmice [Table 2]. Gα(olf) ex-
pression did not show significant changes in any brain region in either mouse line at P14
[Table 2]. The ventral midbrain showed significant decreases in the expression of D1R and
D2R in the Dyt1 KO line at P60. Our data demonstrate that impairment of dopaminergic neu-
rotransmission is a common theme in two of the four mouse models of DYT1 dystonia exam-
ined here, and that reduction in the expression of D1R but not D2R may begin early in the
juvenile period. Interestingly, there was no evidence of significantly increased expression of
D1R, D2R or Gα(olf) in any of the regions investigated, at either postnatal age, and in any of
the mouse lines examined, indicating that a common feature of the DYT1 phenotype is attenu-
ation, rather than enhancement of dopamine receptor signaling.
Although the effects of the loss of one wild type Dyt1 allele in the Dyt1 KOmouse and the
introduction of one copy of the ΔGAG allele in the Dyt1 KI mouse produced comparable ef-
fects on D1R and D2R expression at P60 in terms of the direction of the change (decreased ex-
pression of both proteins and in both genotypes; Table 1), there were differences between the
two mouse lines in terms of the magnitude of the effects [Table 3]. Thus, at P60, the Dyt1 KO
line showed greater decreases compared to the Dyt1 KI line [Table 3] in D2R expression levels
in the frontal cortex. In other words, loss of the wild type torsinA and introduction of the
Table 3. A comparison of the magnitude of reductions in D1R and D2R protein expression.
D1R D2R
P60—FC No change KO > KI
P60—CP KO = KI KO > KI
P14—FC No change No change
P14—CP KO > KI No change
A comparison of the magnitude of reductions in D1R and D2R protein expression in the frontal cortex (FC)
and caudate putamen (CP) of postnatal day 60 (P60) and postnatal day 14 (P14) Dyt1 KO (KO) and Dyt1
KI (KI) mice.
doi:10.1371/journal.pone.0123104.t003
Dopamine Receptors and DYT1 Dystonia
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mutant torsinA produced a difference in the magnitude of the effect on D1R and D2R expres-
sion at P60. Molecular insights into the mechanisms of such differential effects were not possi-
ble. However, both the D1R and D2R mediated pathways, the direct and indirect striatal
pathways, respectively may be compromised in DYT1 dystonia, as suggested in earlier reports
from other laboratories [39–41]
There were differences in the presence or absence of an effect on D1R expression between
Dyt1 KO and Dyt1 KI lines in a brain region-dependent manner at P14 [Table 3]. Thus, D1R
expression in the caudate-putamen was decreased in the Dyt1 KO line and was unaffected in
the Dyt1 KI line. Interestingly, D2R expression was unaffected in either mouse line in either
brain region at P14 [Table 2]. Thus, loss of the wild type torsinA and introduction of the mu-
tant torsinA produced markedly different effects on dopamine receptor expression at P14, sug-
gesting that the developmental stage is an important variable in modifying the effects of
torsinA on dopamine receptor expression.
Here we wish to emphasize two points from the literature. First, a patch-clamp study of the
DYT1 hMTmouse line showed significant impairment of D2R signaling in striatal cholinergic
interneurons at P10. Since the cholinergic interneurons constitute a very small proportion of
striatal cells (<1% of neurons), it is possible that our western blot data did not detect potential
changes in D2R expression in the DYT1 hMT line or other lines at P14. Second, it would have
been interesting to correlate changes in D1R expression at P14 with behavioral changes at early
developmental stages in a genotype-phenotype correlation. However, unfortunately, for the
mouse lines used in this study phenotype analysis during development (e.g. P14) has not been
performed. The only relevant behavioral analysis may be the one in Dyt1 KI (heterozygous)
mice at 3- and 6-months of age, where a deficit in beam walking was noted at 6-months but
not at 3-months [20].
That ontogenetic factors may modify torsinA’s effects on dopamine receptor expression is
not unexpected. For example, expression of D1R and D2R mRNA and protein, relative distri-
bution of receptor binding sites, and behavioral consequences of receptor activation show
brain region-specific ontogenetic changes [42,43]. Although these developmental changes may
not fully correlate with one another (e.g. changes in mRNA and protein expression for the
same receptor may not correlate with each other), it appears that dopamine receptor expression
and function undergo significant region-specific remodeling during development. The cell bio-
logical mechanisms underlying the developmental changes likely include mRNA and protein
trafficking, membrane recycling and protein conformational changes in response to the chang-
ing functional demands on the neurotransmitter signaling machinery of the developing animal.
TorsinA is thought to be involved in all these cellular processes [44–46], suggesting im-
pairment of one or more of these processes in our mouse models as a contributor to the de-
crease in D1R, D2R or Gα(olf) proteins.
We observed a decrease in D1R but not D2R expression at P14, whereas both the receptors
were decreased at P60 in multiple brain regions in the KO and KI lines. The relative abundance
of the D1R versus D2R shows significant ontogenetic changes [25,42,43], which could underlie
the differential susceptibilities of the two proteins during the juvenile period to changes in tor-
sinA expression or function. Another consideration is the potential compensatory effects of
torsinB, which shares 70% homology with torsinA [6]. We have shown previously that torsinA
expression in the brain is high during development and low at maturity, whereas torsinB ex-
pression shows the opposite trend (low during development and high at maturity) [24]. How-
ever, the expression of torsinB in the mouse models used in the present study is not fully
characterized. Therefore, a role for torsinB in the modulation of the effects of torsinA on dopa-
mine receptor protein expression remains speculative.
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Introduction of the human ΔGAG allele (hMT) and the human wild type DYT1 (hWT) pro-
duced no significant effects on D1R, D2R or Gα(olf) protein expression in any brain region at
P60. Earlier studies using electrophysiological methods showed functional deficits in dopamine
D2R in the striatum of the hMT line [40] and behavioral analyses showed motor learning defi-
cits in this mouse line [21]. The lack of significant changes in the expression of any of the pro-
teins in the present study may be due to the global nature of the present analyses (i.e. protein
expression analysis rather than functional analysis of the receptors).
Expression of the Gα(olf) protein was significantly decreased in the frontal cortex and ven-
tral midbrain of the Dyt1 KO line. Recent evidence suggests that mutations in the Gα(olf) gene
(GNAL) are associated with generalized dystonia [18]. Gα(olf) is enriched in neurons of the
caudate-putamen. However, we did not observe significant changes in Gα(olf) expression in
the caudate-putamen in any of the mouse lines.
Finally D1R and D2R expression was affected in the midbrain region only in the Dyt1 KO
line. This may represent an example of region-specificity of the effects of the loss of torsinA.
Alternatively, since the expression of D1R and D2R is relatively low in the ventral midbrain
compared to the other brain regions, it is possible that our techniques are not sensitive enough
to detect additional changes.
In summary our data show that dopamine D1R, D2R and Gα(olf) protein expression is vul-
nerable to the loss of torsinA as well as introduction of the mouse ΔGAGmutation. The Dyt1
KO and Dyt1 KI lines showed the most marked reductions in the expression of the proteins.
The decrease in D1R occurred in the juvenile period (P14) and preceded the decreases in D2R
and Gα(olf) expression, the latter occurring only at P60. Thus, changes in D1R signaling may
occur early in postnatal development predisposing the individual carrying the Dyt1mutation
to dystonia beginning at an early age. Our findings represent the first comprehensive study of
the changes in dopamine receptor signaling mechanisms in DYT1 dystonia.
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